300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Social
Infrastructure
Beauty
Fashion
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Bangladesh
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Hungary
Estonia
Grenada
Israel
Lithuania
Honduras
Iceland
Bahamas
Cambodia
Lebanon
Liechtenstein
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Atlantic Bridge University Fund, VC Fund

Atlantic Bridge University Fund

VC Fund

Dublin, Ireland

Atlantic Bridge University Fund is a VC fund in Dublin focused on Health Care and Medical Device. Atlantic Bridge University Fund invest in entrepreneurs with the ambition to create world-class companies of scale. A €60m investment fund to accelerate the commercialisation of ground-breaking research and the scaling of global businesses.

Total investments:
33
Last investment:
Lead investor:
55%

Last updated:

Industries Atlantic Bridge University Fund invests in

Health CareMedical DeviceBig DataArtificial IntelligenceSoftware

Stages Atlantic Bridge University Fund invests in

SeedSeries ASeries BFunding RoundVenture - Series Unknown

Countries Atlantic Bridge University Fund invests in

IrelandUnited States

Round sizes

Seed $859k–$4.2MSeries A $3.4M–$34MSeries B $16M–$80M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$859k–$4.2M
Series A
$3.4M–$34M
Series B
$16M–$80M

Investment Focus

Industry

  • Health Care 5 (15%)
  • Medical Device 5 (15%)
  • Big Data 3 (9%)
  • Artificial Intelligence 3 (9%)
  • Software 2 (6%)
See all 43 industries →

Stage

  • Seed 15 (45%)
  • Series A 7 (21%)
  • Series B 2 (6%)
  • Funding Round 1 (3%)
  • Venture - Series Unknown 1 (3%)

Country

  • Ireland 17 (52%)
  • United States 1 (3%)

Team

NameTitleInvestmentsLinksEmail
Brian Long
Brian Long Founder & Managing Partner
Founder & Managing Partner Total investments: 22
Find email

Investments

CompanyDescriptionRoundLinks
ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. $80M / Series B / Aug 25, 2025
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation $16M / Series B / Aug 07, 2024
PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves. $2.5M / Venture - Series Unknown / May 01, 2022
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation $9.2M / Series A / Feb 04, 2022
ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. Series A / Jan 11, 2022
ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. $34.1M / Series A / Jan 11, 2022
Tympany is a platform for performing minimally invasive ear surgeries, reducing unnecessary mastoidectomys and improving outcomes. $3.9M / Seed / Nov 22, 2021
OneProjects is an Irish-German cardiac imaging specialist. $8M / Series A / Oct 14, 2021
TerminusDB is an open-source full-featured in-memory graph database management system with a rich query language, WOQL.TerminusDB allows for the whole suite of revision control features: branch, merge, squash, rollback, blame, and time-travel. It is about taking data seriously, structuring data to meet business needs, and reducing the coderequired to display, distribute and manipulate data and support great decision making.TerminusDB was previously known as DataChemist, was founded in Dublin, Ireland. $4.3M / Seed / Mar 15, 2021
Parvalis Therapeutics develops novel autoimmune therapies for inflammatory diseases and cancer. Founded in 2020, the company is based in Dublin, Ireland. Seed / Jan 01, 2021
See all 33 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Social
Infrastructure
Beauty
Fashion
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Bangladesh
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Hungary
Estonia
Grenada
Israel
Lithuania
Honduras
Iceland
Bahamas
Cambodia
Lebanon
Liechtenstein
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Atlantic Bridge University Fund invest in?

Atlantic Bridge University Fund invests primarily in Health Care, Medical Device and Big Data startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Atlantic Bridge University Fund's check size?

Atlantic Bridge University Fund typically joins rounds of $859k–$4.2M at Seed, $3.4M–$34M at Series A and $16M–$80M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Atlantic Bridge University Fund participates in.

How do I contact Atlantic Bridge University Fund?

Public channels for Atlantic Bridge University Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Atlantic Bridge University Fund?

The team at Atlantic Bridge University Fund includes Brian Long (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Atlantic Bridge University Fund Atlantic Bridge University Fund Find emails